Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 696 (ZNF696) is a predicted DNA-binding transcription factor belonging to the zinc finger protein family in humans. It is encoded by the ZNF696 gene and consists of 374 amino acids. ZNF696 is thought to participate in a regulatory role in transcription by RNA polymerase II and is localized to the nucleus. While the zinc finger protein family has diverse and significant roles in gene regulation, cell cycle, apoptosis, and disease, there is no specific evidence to date linking ZNF696 individually to a distinct biological pathway, disease, or therapeutic intervention. Aliases include FLJ14129, ZNF696, and zinc finger protein 696. The molecule is not currently recognized as a druggable therapeutic target or diagnostic biomarker.
Not applicable—no known drugs or therapeutic agents target ZNF696
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 696 (ZNF696).